Windlas Biotech Ltd share price logo

Windlas Biotech Share Price (WINDLAS)

Check the latest share price of Windlas Biotech, along with the price target, peer comparison, quarterly results, recent news, expert analysis, shareholding pattern, and other key fundamentals to make informed investment decisions.

₹932.550.2%

as on 04:01PM, 13 Jun 2025

NSE

bell
The current prices are delayed by 15 mins, login to check live prices.

Windlas Biotech Stock Performance

Get live Windlas Biotech share price, day's high and low, historical returns, and market stats.

  • Day's Low

    Day's High

    ₹906
    Day's Price Range
    ₹935.45
  • 52 Week's Low

    52 Week's High

    ₹652.75
    52-Week Price Range
    ₹1,198.25
1 Month Return-7.16 %
3 Month Return+ 6.81 %
1 Year Return+ 28.74 %
3 Year Return+ 328.46 %
5 Year Return+ 129.04 %
Previous Close₹930.65
Open₹906.00
Volume34.76K
Upper Circuit₹1,116.75
Lower Circuit₹744.55

Windlas Biotech Fundamentals & Key Indicators

Check Windlas Biotech market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

₹1,949.06 Cr

Return on Equity (ROE)

13.63

PE Ratio (TTM)

31.96

Return on capital employed (ROCE)

18.03

Industry PE ratio

57.39

Beta (LTM)

1.22

P/B Ratio

2.37

Dividend Yield

1.07

PEG Ratio

26.41

Quarterly Earnings Growth YOY

-4.18

EPS (TTM)

27.98

Sector

Pharmaceuticals

Book Value

216.34

Technical Analysis

How to invest in Windlas Biotech?

Investing in Windlas Biotech is simple. You can open a free INDstocks investment account on the INDmoney App. Search for Windlas Biotech or WINDLAS on the app to check live prices of the stock and click on Buy or SIP. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

For example: You can buy 10 shares of Windlas Biotech or start an SIP based on the market price on each investment date.
You can easily transfer money to your stock account via the INDmoney app and start investing in stocks like Windlas Biotech with just a few clicks!

Windlas Biotech Stock's Interest Amongst Investors

7%

Period Jun 15, 2025 to May 16, 2025. Change in 30 Days vs previous period

Search interest for Windlas Biotech Ltd Stock has increased by 7% in the last 30 days, reflecting an upward trend in search activity.

Windlas Biotech Valuation

Track how Windlas Biotech P/E has moved over time to understand its valuation trends.

Windlas Biotech in the last 5 years

  • Overview

  • Trends

Lowest (10.46x)

March 28, 2023

Today (31.96x)

June 13, 2025

Industry (57.39x)

June 13, 2025

Highest (38.93x)

December 6, 2024

LowHigh

Today’s Price to Earnings Ratio: 31.96x

Windlas Biotech Financial Results

Get the annual and quarterly financial summary of Windlas Biotech, including revenue, profit, loss and more.

Value in ₹ crore
DetailsQ4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25
Revenue

(in ₹ Cr)

171 (0%)175 (2%)187 (7%)195 (4%)203 (4%)
Net Income

(in ₹ Cr)

17 (0%)13 (21%)16 (16%)16 (1%)16 (4%)
Net Profit Margin9.92% (0%)7.70% (22%)8.37% (9%)7.99% (5%)8.03% (0%)
Value in ₹ crore
DetailsFY21FY22FY23FY24
Total Assets

(in ₹ Cr)

296 (0%)492 (66%)531 (8%)629 (19%)
Total Liabilities

(in ₹ Cr)

97 (0%)97 (0%)128 (32%)179 (40%)
Value in ₹ crore
DetailsFY20FY21FY22FY23FY24
Operating Cash Flow

(in ₹ Cr)

21 (0%)11 (45%)9 (21%)61 (578%)109 (79%)

Indices Featuring Windlas Biotech Stock

Check stock indices that include Windlas Biotech.

BSE Small-Cap

₹53,370.29

-0.3 (-161.18%)

BSE Healthcare

₹43,995.31

0.08 (34.42%)

Windlas Biotech Earnings and Dividends

View detailed summary of the earnings and dividend history of Windlas Biotech.

  • Windlas Biotech Ltd Earnings Results

    Windlas Biotech Ltd’s net profit fell -4.18% since last year same period to ₹16.28Cr in the Q4 2024-2025. On a quarterly growth basis, Windlas Biotech Ltd has generated 4.49% jump in its net profits since last 3-months.

    Read More about Earnings Results
  • Windlas Biotech Ltd Dividends May,2024

    In the quarter ending March 2024, Windlas Biotech Ltd has declared dividend of ₹5.50 - translating a dividend yield of 0.59%.

    Read More about Dividends

Windlas Biotech Shareholding Pattern

View the shareholding pattern breakup of promoters, FIIs, DIIs, and retail investors in Windlas Biotech.

InvestorsHoldings %Quarterly Trend3M change
Promoter Holdings
62.34%
0.00
Foreign Institutions
1.52%
0.00
Mutual Funds
6.7%
0.00
Retail Investors
25.25%
0.00
Others
4.19%
0.00

Windlas Biotech vs Peers

Compare market cap, revenue, PE, and other key metrics of Windlas Biotech with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
NA1,949.0625.81%0.5158630
NA6.245.19%5.69NANA
NA81.5858.65%0.51140
NA69.916.88%0.78245
NA375.2830.71%0.51NANA

Windlas Biotech News & Key Events

Latest news and events in one place to help you make informed investing decisions in Windlas Biotech.

  • Windlas Biotech Reports Mixed Financial Results - 27 May, 2025

    Windlas Biotech's consolidated net sales for March 2025 reached Rs 202.71 crore, up 18.34% year-on-year. However, net profit declined by 4.19% to Rs 16.28 crore, and EPS decreased to Rs 7.77 from Rs 8.17. EBITDA increased by 15.27%.
  • Windlas Biotech Faces Decline Amid Market Trends - 23 May, 2025

    Windlas Biotech Ltd has experienced a 9.89% decline over the past month, underperforming the BSE Healthcare index and SENSEX. The stock fell 4.88% today, trading at Rs 923, after reaching a record high of Rs 1197 on November 6, 2024, and a 52-week low of Rs 552.85 on June 4, 2024.

Insights on Windlas Biotech Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 10 quarters, 121.87 Cr → 207.64 Cr (in ₹), with an average increase of 5.7% per quarter

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 2 quarters, 15.58 Cr → 16.28 Cr (in ₹), with an average increase of 4.3% per quarter

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, WINDLAS has outperformed top 5 stocks with highest market-cap in Pharmaceuticals

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Divis Laboratories Ltd has given 45.3% return, outperforming this stock by 16.6%

  • imgNEGATIVE IMPACT

    FII Holding Down

    img

    Foreign Institutions have decreased holdings from 1.55% to 1.52% in Mar 2025 quarter

  • imgNEGATIVE IMPACT

    MF Holding Down

    img

    Mutual Funds have decreased holdings from 7.11% to 6.70% in Mar 2025 quarter

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 1 month, WINDLAS stock has moved down by -7.2%

  • imgNEGATIVE IMPACT

    Promoter Holding Down

    img

    Promoters have decreased holdings from 62.51% to 62.34% in Mar 2025 quarter

  • imgNEGATIVE IMPACT

    Retail Holding Down

    img

    Retail Investor have decreased holdings from 25.68% to 25.25% in Mar 2025 quarter

About Windlas Biotech

Windlas Biotech Ltd was founded in 2001 and is a leading provider of pharmaceutical services, development, manufacturing services, and products. The company has a manufacturing plant in Dehradun, Uttarakhand, India and a sales force and distribution network across 14 states. Additionally, it provides CDMO services and products, domestic trade generics and OTC brands, and exports. The company specializes in complex generics products and fixed dose combinations linked to lifestyle-related diseases, as well as drug-device combos. It has adopted high quality systems across its factories and processes that span from product innovation to customer intake. In addition to this, multiple vendors are approved and assessed for sourcing the raw materials.

Revenue: ₹202.71Cr as on March 2025 (Q4 FY25)
Net Profit: ₹16.28Cr as on March 2025 (Q4 FY25)
Listing date: 16 Aug, 2021
Chairperson Name: Vivek Dhariwal
OrganisationWindlas Biotech Ltd
HeadquartersGurgaon
IndustryPharmaceuticals
CEOVivek Dhariwal
E-voting on sharesClick here to vote

FAQs

What is Windlas Biotech share price today?

Windlas Biotech share price today stands at ₹932.55, Open: ₹906, Previous Close: ₹930.65, High: ₹935.45, Low: ₹906, 52 Week High: ₹1198.25, 52 Week Low: ₹652.75.

What is today's traded volume of Windlas Biotech?

Today's traded volume of Windlas Biotech is 34.76K. Which means that 34.76K shares of Windlas Biotech were bought and sold on the stock market during today's trading session.

What is Windlas Biotech's market cap today?

Today's market capitalisation of Windlas Biotech is ₹1,949.06 Cr. Market cap or market capitalisation is the total value of a company’s outstanding shares in the stock market, calculated by multiplying the current share price by the total number of shares issued by the company.

What is the 52 week high and 52 week low range of Windlas Biotech?

Windlas Biotech’s 52 week high is ₹1198.25 and 52 week low is ₹652.75. The current share price of Windlas Biotech is ₹932.55, which is -22.17% down from its 52 week high and 42.86% up from its 52 week low.